Our current state and our future seems to be surrounded by cell phones. Just because this is the way of life does not mean that it has to be harmful to our bodies. Technologies and CeL-Factor TM have developed an EMF radition protection device that will help cell users know when levels are dangerous. The device will read head tissue temp and help users blood remain in a normal state.
During the CTIA convention held in New Orleans, LA, May 8 thru 10, 2012, von Hoffmann and Partner Technologies and CeL-Factor(TM), LLC introduced their line of EMF radiation protection devices to the industry and the public.
CeL-Factor’s(TM) philosophy is one of better living for the entire family and calls for an all-encompassing protection of our bodies…inside and out. We now live in a world where wireless technology is an important part of our business and personal lives, to the point where wireless communications touches nearly every aspect of our daily existence even to the point of being status symbols and trophies of achievement. As our individual futures depend more and more on these technologies, von Hoffmann and Partner Technologies believes that it is necessary to protect our lives as well as enhance them. They believe that their technological advancement of Energetic Quanta Cymatics Communication Technology (EQCCT) optimizes and protects the quality of life for each wireless device consumer. Therefore, they continue to challenge the status quo.
The line of products released at CTIA, called CeL-Factor(TM) utilizes the Energetic Quanta Cymatics Communication Technology (EQCCT) that has demonstrated, after years of clinical testing, real benefits to wireless users. This technology especially helps cell phone users in two ways: 1) to help keep a person’s head tissue temperature cooler when they use a cell phone and 2) help a cell phone user’s blood remain in a more normal state.
November 14-18, 2011, von Hoffmann and Partner Technologies and in particular their new product, CeL-Factor(TM), participated in a comprehensive double-blind, randomized placebo based study conducted at the world renowned Jasper Clinical Research and Development, Inc. This comprehensive double blind study was conducted on the company’s product, CeL-Factor(TM) to determine its effectiveness in diminishing the harmful effects of EMF radiation…Continue Reading
Read more about knoxville avaya systems.